PATENT CLAIM ANALYSIS

Application Number: 16008662
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["536", "023100"]

Abstract:
The present disclosure relates to cap analogs, which can result in high levels of capping efficiency and transcription and improved translation efficiencies. The present disclosure also relates to methods useful for preparing cap analogs and using mRNA species containing such analogs, as well as kits containing the novel cap analogs.

Claim (Index 1):
An RNA molecule having a 5\u2032 end comprising a compound of formula (III): wherein B 1  is R a , R b , and R c  are H; R 1  is CH 3 ; B 2  is R d , R e , and R f  are H; X 1  is N or N + (CH 3 ); X 2  is O; R 20 , R 21 , R 22 , and R 23  are H; R 27  and R 28  are OH; R 2  is OR 3 ; R 3  is H or CH 3 ; and Y 2  is wherein indicates an attachment point.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 94.0
- Lexical Diversity: 1.42105
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16008655', '16008658', '15326059', '15674107', '15674872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5658207002517338
- 35 USC 102 Novelty (BERT): 0.5197149478799392
- Combined Prediction Score: 0.5612101250145544
- Mean Citation Score: 260.879344
- Max Citation Score: 332.56085
- Similarity Product: 296.8164006153345

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test